Anwar Mohamed Al-Ryami
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Anwar Mohamed Al-Ryami has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Abbas Mohamed Al-Azab
Biological Science Department, Faculty of Science, Sana'a University, Yemen
1 shared publication - Fathi Mohammed Al-Azab
Sana’a University, Faculty of Science, Sana’a, Yemen
1 shared publication - Nedhal Abdulmawla Al-Selwi
Chemistry Department, Faculty of Science, Sana’a University, Sana’a, Yemen
1 shared publication - Yasmin M. S. Jamil
Department of Chemistry, Faculty of Science, Sana’a University, Sana’a, Yemen
1 shared publication
Latest Publications
- Open Access
- 21 August 2024
- Published by Ecletica Quimica in Ecletica Quimica
- Vol. 49
Evaluation of the effectiveness of new mixed ligand complexes against the vector of Dengue fever Aedes aegypti (Diptera; Culicidae)
Chloroquine phosphate with ibuprofen and sulphamethoxazole were used as mixed ligands with Ni(II), Co(II), Cu(II), and Zn(II) to prepare new transition metal complexes. Metal analysis, IR, and X-ray diffraction (XRD) spectrum analyzes were used to describe them, with some modifications to the World Health Organization (WHO) standard susceptibility test under laboratory conditions. The biological effects of ligands and new complexes against Aedes aegypti mosquito larvae were evaluated at various concentrations. To assess larvicidal efficacy, late third or early fourth instar larvae were exposed to multiple concentrations of the examined compounds, ranging from 50 to 1000 ppm. Cu(II) complexes revealed significant high activity (LC50 = 100 ppm against Ae. Aegypti was compared with the rest of the metal complexes. On the other hand, the Co(II) complex showed no activity against Ae. aegypti. These mixed ligand complexes seemed to be an alternative method for manufactured insecticides to control larvae of this medically important mosquito vector Ae. aegypti. Further research on other metal complex compounds responsible for larvicidal efficacy will be required.
- 21 August 2024
- Published by Ecletica Quimica in Ecletica Quimica
- Vol. 49
Open AccessEvaluation of the effectiveness of new mixed ligand complexes against the vector of Dengue fever Aedes aegypti (Diptera; Culicidae)
Chloroquine phosphate with ibuprofen and sulphamethoxazole were used as mixed ligands with Ni(II), Co(II), Cu(II), and Zn(II) to prepare new transition metal complexes. Metal analysis, IR, and X-ray diffraction (XRD) spectrum analyzes were used to describe them, with some modifications to the World Health Organization (WHO) standard susceptibility test under laboratory conditions. The biological effects of ligands and new complexes against Aedes aegypti mosquito larvae were evaluated at various concentrations. To assess larvicidal efficacy, late third or early fourth instar larvae were exposed to multiple concentrations of the examined compounds, ranging from 50 to 1000 ppm. Cu(II) complexes revealed significant high activity (LC50 = 100 ppm against Ae. Aegypti was compared with the rest of the metal complexes. On the other hand, the Co(II) complex showed no activity against Ae. aegypti. These mixed ligand complexes seemed to be an alternative method for manufactured insecticides to control larvae of this medically important mosquito vector Ae. aegypti. Further research on other metal complex compounds responsible for larvicidal efficacy will be required.